Capricor Therapeutics
CAPR
#8025
Rank
S$0.37 B
Marketcap
S$8.10
Share price
-4.36%
Change (1 day)
-58.09%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -S$0.11 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are S$11.13 Million. In 2024 the company made an earning of -S$51.54 Million a decrease over its 2023 earnings that were of -S$28.39 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.11 Billion107.77%
2024 -S$51.54 Million81.57%
2023 -S$28.39 Million-23.2%
2022 -S$36.96 Million44.93%
2021 -S$25.5 Million46.61%
2020 -S$17.4 Million78.71%
2019 -S$9.74 Million-49.7%
2018 -S$19.35 Million-724.78%
2017 S$3.09 M-112.93%
2016 -S$23.95 Million46.27%
2015 -S$16.38 Million106.82%
2014 -S$7.92 Million-48.41%
2013 -S$15.35 Million977.23%
2012 -S$1.43 Million-77.11%
2011 -S$6.23 Million-22.35%
2010 -S$8.02 Million-20.17%
2009 -S$10.04 Million-41.17%
2008 -S$17.07 Million41.05%
2007 -S$12.1 Million1098.87%
2006 -S$1.01 Million4101.55%
2005 -S$0.03 Million-0.97%
2004 -S$0.03 Million17.87%
2003 -S$0.03 Million3.66%
2002 -S$0.02 Million-30.11%
2001 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.25 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.74 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$0.96 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.33 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$6.11 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.09 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA